HIM
RMD icon

Hillsdale Investment Management’s ResMed RMD Stock Holding History

Hillsdale Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,770
Closed -$715K – 722
2025
Q2 		$715K Sell
2,770
-600
-18% -$143K 0.03% 363
2025
Q1 		$754K Buy
3,370
+100
+3% +$23.3K 0.04% 292
2024
Q4 		$748K Buy
3,270
+100
+3% +$24.1K 0.04% 301
2024
Q3 		$774K Buy
+3,170
New +$708K 0.06% 271
2020
Q4 		– Sell
-45
Closed -$8K – 650
2020
Q3 		$8K Hold
45
– – ﹤0.01% 511
2020
Q2 		$9K Buy
+45
New +$7.36K ﹤0.01% 481

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Hillsdale Investment Management's RMD Position: Q3 2025 in Review

Hillsdale Investment Management sold out of ResMed (RMD) in Q3 2025, closing a stake of 2,770 shares — an estimated $715K sold.

Hillsdale Investment Management first reported a position in RMD in Q2 2020 and held it in 6 quarters. The position peaked at $774K in Q3 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Hillsdale Investment Management reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 2,770 ResMed shares in Q3 2025, an estimated $715K.
  • Hillsdale Investment Management first reported a position in ResMed in Q2 2020 and held it in 6 quarters.
  • Hillsdale Investment Management's ResMed position peaked at $774K in Q3 2024.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.